Cita APA

López-Velazco, J., Manzano, S., Elorriaga, K., Otaño, M., Lahuerta, A., Alvarez, L., . . . Urruticoechea, A. (2025). Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+/HER2-breast cancer uncovers biomarkers of tumour response.

Citación estilo Chicago

López-Velazco, JI, et al. Molecular Characterisation of the Residual Disease After Neoadjuvant Endocrine Therapy in ER+/HER2-breast Cancer Uncovers Biomarkers of Tumour Response. 2025.

Cita MLA

López-Velazco, JI, et al. Molecular Characterisation of the Residual Disease After Neoadjuvant Endocrine Therapy in ER+/HER2-breast Cancer Uncovers Biomarkers of Tumour Response. 2025.